These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 12708190)

  • 1. [Quality of life in dermatology: Tunisian version of the Skindex-29].
    Zghal A; Zeglaoui F; Kallel L; Karmous R; Ben Ammar H; Labbane R; Kammoun MR
    Tunis Med; 2003 Jan; 81(1):34-7. PubMed ID: 12708190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Categorization of Skindex-29 scores using mixture analysis.
    Nijsten T; Sampogna F; Abeni D
    Dermatology; 2009; 218(2):151-4. PubMed ID: 19060458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of vitiligo on self-reported health-related quality of life.
    Ongenae K; Van Geel N; De Schepper S; Naeyaert JM
    Br J Dermatol; 2005 Jun; 152(6):1165-72. PubMed ID: 15948977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Willingness-to-pay and quality of life in patients with vitiligo.
    Radtke MA; Schäfer I; Gajur A; Langenbruch A; Augustin M
    Br J Dermatol; 2009 Jul; 161(1):134-9. PubMed ID: 19298268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of categories at risk for high quality of life impairment in patients with vitiligo.
    Sampogna F; Raskovic D; Guerra L; Pedicelli C; Tabolli S; Leoni L; Alessandroni L; Abeni D
    Br J Dermatol; 2008 Aug; 159(2):351-9. PubMed ID: 18565189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measuring quality of life of patients with different clinical types of psoriasis using the SF-36.
    Sampogna F; Tabolli S; Söderfeldt B; Axtelius B; Aparo U; Abeni D;
    Br J Dermatol; 2006 May; 154(5):844-9. PubMed ID: 16634884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life and emotional state in vitiligo in an Estonian sample: comparison with psoriasis and healthy controls.
    Karelson M; Silm H; Kingo K
    Acta Derm Venereol; 2013 Jul; 93(4):446-50. PubMed ID: 23306792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychometric properties of the Dermatology Life Quality Index (DLQI) in 900 Italian patients with psoriasis.
    Mazzotti E; Barbaranelli C; Picardi A; Abeni D; Pasquini P
    Acta Derm Venereol; 2005; 85(5):409-13. PubMed ID: 16159732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting responses on Dermatology Life Quality Index items among vitiligo sufferers.
    Kent G; al-Abadie M
    Clin Exp Dermatol; 1996 Sep; 21(5):330-3. PubMed ID: 9136149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. German adaptation of the Skindex-29 questionnaire on quality of life in dermatology: validation and clinical results.
    Augustin M; Wenninger K; Amon U; Schroth MJ; Küster W; Chren M; Kupfer J; Gieler U
    Dermatology; 2004; 209(1):14-20. PubMed ID: 15237262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DLQI scores in vitiligo: reliability and validity of the Persian version.
    Aghaei S; Sodaifi M; Jafari P; Mazharinia N; Finlay AY
    BMC Dermatol; 2004 Aug; 4():8. PubMed ID: 15294022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of quality of life in patients with toenail onychomycosis by Polish version of an international onychomycosis-specific questionnaire.
    Szepietowski JC; Reich A; Pacan P; Garlowska E; Baran E;
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):491-6. PubMed ID: 17373976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of psoriasis on quality of life in Kuwait.
    Al-Mazeedi K; El-Shazly M; Al-Ajmi HS
    Int J Dermatol; 2006 Apr; 45(4):418-24. PubMed ID: 16650169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Turkish version of Skindex-29.
    Aksu AE; Urer MS; Sabuncu I; Saracoglu ZN; Chren MM
    Int J Dermatol; 2007 Apr; 46(4):350-5. PubMed ID: 17442071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arabic version of Skindex-16: translation and cultural adaptation, with assessment of reliability and validity.
    AlGhamdi KM; AlShammari SA
    Int J Dermatol; 2007 Mar; 46(3):247-52. PubMed ID: 17343578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized placebo-controlled double-blind study of levamisole in the treatment of limited and slowly spreading vitiligo.
    Agarwal S; Ramam M; Sharma VK; Khandpur S; Pal H; Pandey RM
    Br J Dermatol; 2005 Jul; 153(1):163-6. PubMed ID: 16029343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Psychiatric morbidity and quality of life in Vitiligo: a case controlled study].
    Mechri A; Amri M; Douarika AA; Ali Hichem BH; Zouari B; Zili J
    Tunis Med; 2006 Oct; 84(10):632-5. PubMed ID: 17193855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NailQoL: a quality-of-life instrument for onychomycosis.
    Warshaw EM; Foster JK; Cham PM; Grill JP; Chen SC
    Int J Dermatol; 2007 Dec; 46(12):1279-86. PubMed ID: 18173524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in quality of life in persons with eczema and psoriasis after treatment in departments of dermatology.
    Wahl AK; Mørk C; Lillehol BM; Myrdal AM; Helland S; Hanestad BR; Moum T
    Acta Derm Venereol; 2006; 86(3):198-201. PubMed ID: 16710574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psoriasis has a major secondary impact on the lives of family members and partners.
    Eghlileb AM; Davies EE; Finlay AY
    Br J Dermatol; 2007 Jun; 156(6):1245-50. PubMed ID: 17459044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.